Clinical Gynecologic Oncology, 9th Edition
Opis
The most readable, most comprehensive book in its field, Clinical Gynecologic Oncology, 9th Edition is the leading reference for diagnosis and treatment of gynecologic cancers - a must-have reference for improving outcomes and providing effective care. A "who's who" list of contributing authors, under the editorial direction of Drs. Philip DiSaia and William Creasman, provides expert guidance on clinical presentations and management, now fully up to date with a brand-new design for faster, easier reference.
Key Features
- Contains useful appendices covering staging, screening, nutritional therapy, toxicity criteria, blood component therapy, and radiation therapy.
- Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, videos, and references from the book on a variety of devices.
New to this Edition
- Covers hot topics such as multi-panel genetic testing, target therapies, sentinel node concept in endometrial cancer and vulvar cancer, and robotic surgery.
- Updates include new quick-reference features such as key point boxes with bulleted lists, highlighted key text, enhanced chapter outlines, and a brand-new design throughout.
- Includes up-to-date references and algorithms, making this text a comprehensive resource for clinical practice, personal study, and exam review.
- Helps you take advantage of the latest advances in early detection and improved treatment options for gynecologic cancers, especially uterine and cervical cancers.
Author Information
By Philip J. DiSaia, MD, The Dorothy Marsh Chair in Reproductive Biology, Professor, Department of Obstetrics and Gynecology, University of California, Irvine College of Medicine, Irvine, California, UCI Medical Center, Orange, California; William T. Creasman, MD, Sims-Hester Professor and Chairman, Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC; Robert S Mannell, MD, Professor and James A. Merrill Chair, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; D. Scott McMeekin, MD, Presbyterian Foundation Presidential Professor, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma and David G Mutch, MD, Judith and Ira Gall Professor of Gynecologic Oncology; Obstetrics and Gynecology Division Chief, Washington University School of Medicine, St. Louis, Missouri
